MedPath

Probiotics for Preterm Infants

Not yet recruiting
Conditions
Preterm Infant Feeding Outcomes
Probiotic
Registration Number
NCT06885944
Lead Sponsor
Ankara City Hospital Bilkent
Brief Summary

Probiotics will be used for preterm infants under 32 weeks of gestation and under 1500 g birthweight. Our aim was to investigate the effects of probiotics for stable preterm infants after extubation and who reached full enteral feeding. There are some hesitations among care-givers to start probiotics early due to safety issues although there are many positive effects of these products reported int the literature.

Detailed Description

Our study included premature babies with a birth weight of less than 1500 grams, born at less than 32 weeks of gestation, and without congenital anomalies.

Approval was obtained from the hospital's clinical research ethics committee before starting the study. The decision to start probiotics was made when these premature babies were fully enteral fed. The study design was created as a cohort and case-control study (No randomisation). When clinicians decided to start probiotic support for premature babies with good general health and no additional problems, probiotics were added to the baby's order.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

<32 weeks, <1500 g birthweight -

Exclusion Criteria

Congential anomalies, still parenteral feeding, BW<800 gr and <23 weeks of GA

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antropometric measures2 months

daily weight gain mg/kg/day

Secondary Outcome Measures
NameTimeMethod
Metabolic profile2 months

Ca, P, ALP, Urea and biochmeical markers for nutritional status

© Copyright 2025. All Rights Reserved by MedPath